Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion

FASEB Journal

Volumn 22, Issue 12, 2008, Pages 4228-4238

  Leoni, Giovanna ^a   Patel, Hetal B ^a   Sampaio, André L F ^a   Gavins, Felicity N E ^a,d   Murray, Joanne F ^c   Grieco, Paolo ^b   Getting, Stephen J ^c   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF WESTMINSTER   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Cell trafficking; GPCR; Intravital microscopy

Indexed keywords

CXCL1 CHEMOKINE; GAMMA INTERMEDIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; TRYPTOPHAN;

ANIMAL EXPERIMENT; ARTICLE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FRAMESHIFT MUTATION; ISCHEMIA; MALE; MESENTERY BLOOD FLOW; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY;

ANIMALS; ANTIGENS, CD11B; CELL ADHESION; CELL MOVEMENT; CHEMOKINE CCL2; CHEMOKINE CXCL1; DOWN-REGULATION; FRAMESHIFT MUTATION; INFLAMMATION; INFLAMMATION MEDIATORS; L-SELECTIN; MALE; MELANOCYTE-STIMULATING HORMONES; MESENTERY; MICE; MICROCIRCULATION; PHENOTYPE; RECEPTOR, MELANOCORTIN, TYPE 3; REPERFUSION INJURY;

ANIMALIA; MUS;

EID: 57349184220     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.08-113886     Document Type: Article

References (47)

1. Ley, K., Laudanna, C., Cybulsky, M. I., and Nourshargh, S. (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678-689
2. Gilroy, D. W., Lawrence, T., Perretti, M., and Rossi, A. G. (2004) Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3, 401-416
3. Newby, A. C. (2005) Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev. 85, 1-31
4. Wainwright, C. L. (2004) Matrix metalloproteinases, oxidative stress and the acute response to acute myocardial ischemia and reperfusion. Curr. Opin. Pharmacol. 4, 132-138
5. Perretti, M. (1997) Endogenous mediators that inhibit the leukocyte-endothelium interaction. Trends Pharmacol. Sci. 18, 418-425
6. Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A., Perretti, M., Rossi, A. G., and Wallace, J. L. (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325-332
7. Gonzalez-Rey, E., Chorny, A., and Delgado, M. (2007) Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat. Rev. Immunol. 7, 52-63
8. Serhan, C. N., and Savill, J. (2005) Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6, 1191-1197
9. Lim, L. H., Solito, E., Russo-Marie, F., Flower, R. J., and Perretti, M. (1998) Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc. Natl. Acad. Sci. U. S. A. 95, 14535-14539
10. Damazo, A. S., Yona, S., Flower, R. J., Perretti, M., and Oliani, S. M. (2006) Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis. J. Immunol. 176, 4410-4418
11. Bazzani, C., Guarini, S., Botticelli, A. R., Zaffe, D., Tomasi, A., Bini, A., Cainazzo, M. M., Ferrazza, G., Mioni, C., and Bertolini, A. (2001) Protective effect of melanocortin peptides in rat myocardial ischemia. J. Pharmacol. Exp. Ther. 297, 1082-1087
12. Mioni, C., Giuliani, D., Cainazzo, M. M., Leone, S., Iannone, C., Bazzani, C., Grieco, P., Novellino, E., Tomasi, A., Bertolini, A., and Guarini, S. (2003) Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC(3) receptors. Eur. J. Pharmacol. 477, 227-234
13. Getting, S. J., Di Filippo, C., Christian, H. C., Lam, C. W., Rossi, F., D'Amico, M., and Perretti, M. (2004) MC-3 receptor and the inflammatory mechanisms activated in acute myocardial infarct. J. Leukoc. Biol. 76, 845-853
14. Gatti, S., Colombo, G., Buffa, R., Turcatti, F., Garofalo, L., Carboni, N., Ferla, L., Fassati, L. R., Lipton, J. M., and Catania, A. (2002) alpha-Melanocyte-stimulating hormone protects the allograft in experimental heart transplantation. Transplantation 74, 1678-1684
15. Catania, A., Gatti, S., Colombo, G., and Lipton, J. M. (2004) Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev. 56, 1-29
16. Getting, S. J. (2006) Targeting melanocortin receptors as potential novel therapeutics. Pharmacol. Ther. 111, 1-15
17. Ritter, J., Kerr, L. D., Valeriano-Marcet, J., and Spiera, H. (1994) ACTH revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems. J. Rheumatol. 21, 696-699
18. Catania, A., Airaghi, L., Colombo, G., and Lipton, J. M. (2000) Alpha-melanocyte-stimulating hormone in normal human physiology and disease states. Trends Endocrinol. Metab. 11, 304-308
19. Gantz, I., and Fong, T. M. (2003) The melanocortin system. Am. J. Physiol. Endocrinol. Metab. 284, E468-E474
20. Guarini, S., Schioth, H. B., Mioni, C., Cainazzo, M., Ferrazza, G., Giuliani, D., Wikberg, J. E., Bertolini, A., and Bazzani, C. (2002) MC(3) receptors are involved in the protective effect of melanocortins in myocardial ischemia/reperfusion-induced arrhythmias. Naunyn Schmiedebergs Arch. Pharmacol. 366, 177-182
21. Getting, S. J., Christian, H. C., Flower, R. J., and Perretti, M. (2002) Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum. 46, 2765-2775
22. Getting, S. J., Gibbs, L., Clark, A. J., Flower, R. J., and Perretti, M. (1999) POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. J. Immunol. 162, 7446-7453
23. Kalden, D. H., Scholzen, T., Brzoska, T., and Luger, T. A. (1999) Mechanisms of the anti-inflammatory effects of alpha-MSH. Role of transcription factor NF-kappa B and adhesion molecule expression. Ann. N. Y. Acad. Sci. 885, 254-261
24. Manna, S. K., and Aggarwal, B. B. (1998) Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J. Immunol. 161, 2873-2880
25. Lam, C. W., Getting, S. J., and Perretti, M. (2005) In vitro and in vivo induction of heme oxygenase 1 in mouse macrophages following melanocortin receptor activation. J. Immunol. 174, 2297-2304
26. Lam, C. W., Perretti, M., and Getting, S. J. (2006) Melanocortin receptor signaling in RAW264.7 macrophage cell line. Peptides 27, 404-412
27. Colombo, G., Gatti, S., Turcatti, F., Sordi, A., Fassati, L. R., Bonino, F., Lipton, J. M., and Catania, A. (2005) Gene expression profiling reveals multiple protective influences of the peptide alpha-melanocyte-stimulating hormone in experimental heart transplantation. J. Immunol. 175, 3391-3401
28. Chen, A. S., Marsh, D. J., Trumbauer, M. E., Frazier, E. G., Guan, X. M., Yu, H., Rosenblum, C. I., Vongs, A., Feng, Y., Cao, L., Metzger, J. M., Strack, A. M., Camacho, R. E., Mellin, T. N., Nunes, C. N., Min, W., Fisher, J., Gopal-Truter, S., MacIntyre, D. E., Chen, H. Y., and Van der Ploeg, L. H. (2000) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26, 97-102
29. Robbins, L. S., Nadeau, J. H., Johnson, K. R., Kelly, M. A., Roselli-Rehfuss, L., Baack, E., Mountjoy, K. G., and Cone, R. D. (1993) Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72, 827-834
30. Gavins, F. N., Yona, S., Kamal, A. M., Flower, R. J., and Perretti, M. (2003) Leukocyte antiadhesive actions of annexin 1: ALXR-and FPR-related anti-inflammatory mechanisms. Blood 101, 4140-4147
31. Grieco, P., Balse, P. M., Weinberg, D., MacNeil, T., and Hruby, V. J. (2000) D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity. J. Med. Chem. 43, 4998-5002
32. Getting, S. J., Lam, C. W., Chen, A. S., Grieco, P., and Perretti, M. (2006) Melanocortin 3 receptors control crystal-induced inflammation. FASEB J. 20, 2234-2241
33. 8]-gamma-melanocyte-stimulating hormone exhibits anti-inflammatory efficacy in mice bearing a nonfunctional MC1R (recessive yellow e/e mouse). Mol. Pharmacol. 70, 1850-1855
34. Cuzzocrea, S., Tailor, A., Zingarelli, B., Salzman, A. L., Flower, R. J., Szabø, C., and Perretti, M. (1997) Lipocortin 1 protects against splanchnic artery occlusion and reperfusion injury by affecting neutrophil migration. J. Immunol. 159, 5089-5097
35. Di Filippo, C., Rossi, F., Ongini, E., Del Soldato, P., Perretti, M., and D'Amico, M. (2004) The distinct alterations produced in cardiovascular functions by prednisolone and nitro-prednisolone (NCX-1015) in the rat highlight a causal role for endothelin-1. J. Pharmacol. Exp. Ther. 310, 1133-1141
36. Paul-Clark, M., Del Soldato, P., Fiorucci, S., Flower, R. J., and Perretti, M. (2000) 21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties. Br. J. Pharmacol. 131, 1345-1354
37. Luger, T. A., and Brzoska, T. (2007) alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Ann. Rheum. Dis. 66 (Suppl. 3), iii52-55
38. Chiao, H., Kohda, Y., McLeroy, P., Craig, L., Housini, I., and Star, R. A. (1997) Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J. Clin. Invest. 99, 1165-1172
39. Chiao, H., Foster, S., Thomas, R., Lipton, J., and Star, R. A. (1996) Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. J. Clin. Invest. 97, 2038-2044
40. Luger, T. A., Scholzen, T. E., Brzoska, T., and Bohm, M. (2003) New insights into the functions of alpha-MSH and related peptides in the immune system. Ann. N. Y. Acad. Sci. 994, 133-140
41. Getting, S. J., Christian, H. C., Lam, C. W., Gavins, F. N., Flower, R. J., Schioth, H. B., and Perretti, M. (2003) Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor. J. Immunol. 170, 3323-3330
42. Maaser, C., Kannengiesser, K., Specht, C., Lugering, A., Brzoska, T., Luger, T. A., Domschke, W., and Kucharzik, T. (2006) Crucial role of the melanocortin receptor MC1R in experimental colitis. Gut 55, 1415-1422
43. Artuc, M., Bohm, M., Grutzkau, A., Smorodchenko, A., Zuberbier, T., Luger, T., and Henz, B. M. (2006) Human mast cells in the neurohormonal network: expression of POMC, detection of precursor proteases, and evidence for IgE-dependent secretion of alpha-MSH. J. Invest. Dermatol. 126, 1976-1981
44. Lyons, P. D., and Blalock, J. E. (1997) Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes. J. Neuroimmunol. 78, 47-56
45. Squadrito, F., Guarini, S., Altavilla, D., Squadrito, G., Campo, G. M., Arlotta, M., Quartarone, C., Saitta, A., Cucinotta, D., Bazzani, C., Cainazzo, M. M., Mioni, C., Bertolini, A., and Caputi, A. P. (1999) Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock. Br. J. Pharmacol. 128, 816-822
46. Ellacott, K. L., Murphy, J. G., Marks, D. L., and Cone, R. D. (2007) Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling. Endocrinology 148, 6186-6194
47. Butler, A. A., and Cone, R. D. (2002) The melanocortin receptors: lessons from knockout models. Neuropeptides 36, 77-84